• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在西班牙加泰罗尼亚的一项普通人群队列研究中,感染引起的 SARS-CoV-2 血清流行率和抗体反应异质性。

Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain.

机构信息

Barcelona Institute for Global Health (ISGlobal), 08036, Barcelona, Spain.

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

出版信息

Sci Rep. 2021 Nov 3;11(1):21571. doi: 10.1038/s41598-021-00807-4.

DOI:10.1038/s41598-021-00807-4
PMID:34732749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8566562/
Abstract

Sparse data exist on the complex natural immunity to SARS-CoV-2 at the population level. We applied a well-validated multiplex serology test in 5000 participants of a general population study in Catalonia in blood samples collected from end June to mid November 2020. Based on responses to fifteen isotype-antigen combinations, we detected a seroprevalence of 18.1% in adults (n = 4740), and modeled extrapolation to the general population of Catalonia indicated a 15.3% seroprevalence. Antibodies persisted up to 9 months after infection. Immune profiling of infected individuals revealed that with increasing severity of infection (asymptomatic, 1-3 symptoms, ≥ 4 symptoms, admitted to hospital/ICU), seroresponses were more robust and rich with a shift towards IgG over IgA and anti-spike over anti-nucleocapsid responses. Among seropositive participants, lower antibody levels were observed for those ≥ 60 years vs < 60 years old and smokers vs non-smokers. Overweight/obese participants vs normal weight had higher antibody levels. Adolescents (13-15 years old) (n = 260) showed a seroprevalence of 11.5%, were less likely to be tested seropositive compared to their parents and had dominant anti-spike rather than anti-nucleocapsid IgG responses. Our study provides an unbiased estimate of SARS-CoV-2 seroprevalence in Catalonia and new evidence on the durability and heterogeneity of post-infection immunity.

摘要

关于人群层面上对 SARS-CoV-2 的复杂自然免疫力,相关的稀疏数据依然存在。我们在 2020 年 6 月底至 11 月中旬采集的 5000 名加泰罗尼亚一般人群研究参与者的血液样本中应用了一种经过充分验证的多重血清学检测。基于对 15 种同种型抗原组合的反应,我们在成年人(n=4740)中检测到 18.1%的血清阳性率,并通过模型外推到加泰罗尼亚的一般人群,表明血清阳性率为 15.3%。感染后抗体持续存在长达 9 个月。对感染个体的免疫分析表明,随着感染严重程度的增加(无症状、1-3 种症状、≥4 种症状、住院/重症监护),血清反应更加稳健和丰富,IgG 取代 IgA,抗刺突取代抗核衣壳的反应。在血清阳性的参与者中,与<60 岁的人相比,≥60 岁的人抗体水平较低;与不吸烟者相比,吸烟者的抗体水平较低。超重/肥胖参与者的抗体水平高于正常体重者。青少年(13-15 岁)(n=260)的血清阳性率为 11.5%,与他们的父母相比,他们更不可能被检测为血清阳性,并且主要表现为抗刺突 IgG 反应,而不是抗核衣壳 IgG 反应。我们的研究提供了加泰罗尼亚 SARS-CoV-2 血清阳性率的无偏估计,并提供了关于感染后免疫的持久性和异质性的新证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/8566562/c5cce3c9ea5c/41598_2021_807_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/8566562/45d7587fa4bd/41598_2021_807_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/8566562/e9802fca3cdb/41598_2021_807_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/8566562/c5cce3c9ea5c/41598_2021_807_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/8566562/45d7587fa4bd/41598_2021_807_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/8566562/e9802fca3cdb/41598_2021_807_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f87/8566562/c5cce3c9ea5c/41598_2021_807_Fig3_HTML.jpg

相似文献

1
Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain.在西班牙加泰罗尼亚的一项普通人群队列研究中,感染引起的 SARS-CoV-2 血清流行率和抗体反应异质性。
Sci Rep. 2021 Nov 3;11(1):21571. doi: 10.1038/s41598-021-00807-4.
2
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.刺突蛋白与核衣壳蛋白抗体反应的变化影响基于人群的血清流行率研究中对感染的估计。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01828-20.
3
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.加拿大艾伯塔省 COVID-19 大流行前两波期间 SARS-CoV-2 抗体的预疫苗阳性率。
Microbiol Spectr. 2021 Sep 3;9(1):e0029121. doi: 10.1128/Spectrum.00291-21. Epub 2021 Aug 18.
4
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.血清阳性率和体液免疫对 SARS-CoV-2 抗体在中国武汉的持久性:一项纵向、人群水平、横断面研究。
Lancet. 2021 Mar 20;397(10279):1075-1084. doi: 10.1016/S0140-6736(21)00238-5.
5
A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.以色列 6 重抗原微阵列对 COVID-19 初始阶段的血清学快照分析。
Microbiol Spectr. 2021 Oct 31;9(2):e0087021. doi: 10.1128/Spectrum.00870-21. Epub 2021 Oct 6.
6
SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic.新冠疫情期间俄罗斯人群的新冠病毒血清流行率结构
Viruses. 2021 Aug 19;13(8):1648. doi: 10.3390/v13081648.
7
SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.SARS-CoV-2 抗体检测在医护人员中的应用:三种市售抗体检测试剂盒的临床性能比较。
Microbiol Spectr. 2021 Oct 31;9(2):e0039121. doi: 10.1128/Spectrum.00391-21. Epub 2021 Sep 29.
8
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.英格兰东南部人群样本中感染率和无症状 COVID-19 疾病的估计。
J Infect. 2020 Dec;81(6):931-936. doi: 10.1016/j.jinf.2020.10.011. Epub 2020 Oct 15.
9
SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.SARS-CoV-2 血清流行率,以及感染后 IgG 浓度和假病毒中和抗体滴度与 HIV 状态的比较:一项匹配的病例对照观察研究。
Lancet HIV. 2021 Jun;8(6):e334-e341. doi: 10.1016/S2352-3018(21)00072-2. Epub 2021 Apr 29.
10
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study.澳大利亚儿童中 SARS-CoV-2 特异性抗体的血清流行率:一项横断面研究。
PLoS One. 2024 Sep 18;19(9):e0300555. doi: 10.1371/journal.pone.0300555. eCollection 2024.

引用本文的文献

1
Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona.巴塞罗那普通人群中细胞因子和免疫球蛋白的疫情前水平以及感染新冠病毒和患新冠肺炎的风险
Front Public Health. 2025 Aug 20;13:1548456. doi: 10.3389/fpubh.2025.1548456. eCollection 2025.
2
Stability of cytokine and immunoglobulin concentrations in the general population: prepandemic basal concentrations and intraindividual changes until the COVID-19 pandemic.普通人群中细胞因子和免疫球蛋白浓度的稳定性:新冠疫情前的基础浓度及直至新冠疫情期间的个体内变化
Front Public Health. 2025 Jul 2;13:1548379. doi: 10.3389/fpubh.2025.1548379. eCollection 2025.
3

本文引用的文献

1
High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl.奥地利伊施格尔滑雪胜地儿童和成人中新冠病毒血清阳性率很高。
Commun Med (Lond). 2021;1(1):4. doi: 10.1038/s43856-021-00007-1. Epub 2021 Jun 30.
2
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.根据 2020 年 7 月至 2021 年 5 月的献血样本,估计美国感染和疫苗引起的 SARS-CoV-2 血清流行率。
JAMA. 2021 Oct 12;326(14):1400-1409. doi: 10.1001/jama.2021.15161.
3
Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies.
Modelling and investigating memory immune responses in infectious disease. Application to influenza a virus and sars-cov-2 reinfections.
传染病记忆免疫反应的建模与研究。在甲型流感病毒和新冠病毒再感染中的应用。
Infect Dis Model. 2024 Oct 9;10(1):163-188. doi: 10.1016/j.idm.2024.09.009. eCollection 2025 Mar.
4
Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia.在加泰罗尼亚一项基于人群的队列研究中,长新冠的风险、决定因素及持续性。
BMC Med. 2025 Mar 14;23(1):140. doi: 10.1186/s12916-025-03974-7.
5
[The epidemiological survey as a key instrument for events of Public Health importance].[作为具有公共卫生重要性事件关键手段的流行病学调查]
Rev Esp Salud Publica. 2024 Aug 29;98:e202408046.
6
Decoding depression by exploring the exposome-genome edge amidst COVID-19 lockdown.解析大疫情时代的“暴露组-基因组边缘”以探索抑郁症的奥秘
Sci Rep. 2024 Jun 12;14(1):13562. doi: 10.1038/s41598-024-64200-7.
7
Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection.针对 SARS-CoV-2 蛋白的 IgG 和 IgA 滴度及其与轻症 COVID-19 感染症状的关系。
Sci Rep. 2024 Jun 3;14(1):12725. doi: 10.1038/s41598-024-59634-y.
8
Development and Validation of a Highly Sensitive Multiplex Immunoassay for SARS-CoV-2 Humoral Response Monitorization: A Study of the Antibody Response in COVID-19 Patients with Different Clinical Profiles during the First and Second Waves in Cadiz, Spain.用于监测 SARS-CoV-2 体液反应的高灵敏度多重免疫测定法的开发与验证:西班牙加的斯第一波和第二波疫情期间不同临床特征的 COVID-19 患者抗体反应研究
Microorganisms. 2023 Dec 16;11(12):2997. doi: 10.3390/microorganisms11122997.
9
Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy.意大利北部艾米利亚-罗马涅地区一组工人样本中通过抗体反应评估的与SARS-CoV-2感染相关的因素
Antibodies (Basel). 2023 Dec 1;12(4):77. doi: 10.3390/antib12040077.
10
Applications of time series analysis in epidemiology: Literature review and our experience during COVID-19 pandemic.时间序列分析在流行病学中的应用:文献综述及我们在新冠疫情期间的经验
World J Clin Cases. 2023 Oct 16;11(29):6974-6983. doi: 10.12998/wjcc.v11.i29.6974.
多重评估 SARS-CoV-2 抗体可提高检测敏感性,并与中和抗体相关。
Clin Biochem. 2021 Nov;97:54-61. doi: 10.1016/j.clinbiochem.2021.08.006. Epub 2021 Aug 26.
4
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses.SARS-CoV-2 抗体的七个月动力学和人类冠状病毒预先存在抗体的作用。
Nat Commun. 2021 Aug 6;12(1):4740. doi: 10.1038/s41467-021-24979-9.
5
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis.血清学证据表明人类感染 SARS-CoV-2:系统评价和荟萃分析。
Lancet Glob Health. 2021 May;9(5):e598-e609. doi: 10.1016/S2214-109X(21)00026-7. Epub 2021 Mar 8.
6
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection.轻度SARS-CoV-2感染抗体反应中异质性和血清逆转的时间序列分析及机制建模
EBioMedicine. 2021 Mar;65:103259. doi: 10.1016/j.ebiom.2021.103259. Epub 2021 Mar 2.
7
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.新型冠状病毒血清阳性抗体检测与未来感染风险的关系。
JAMA Intern Med. 2021 May 1;181(5):672-679. doi: 10.1001/jamainternmed.2021.0366.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
9
Humoral signatures of protective and pathological SARS-CoV-2 infection in children.儿童保护性和病理性 SARS-CoV-2 感染的体液特征。
Nat Med. 2021 Mar;27(3):454-462. doi: 10.1038/s41591-021-01263-3. Epub 2021 Feb 12.
10
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies.SARS-CoV-2 核衣壳蛋白抗体的免疫原性和交叉反应性:在血清流行率和免疫研究中的应用和局限性。
Transl Res. 2021 Jun;232:60-74. doi: 10.1016/j.trsl.2021.02.006. Epub 2021 Feb 12.